| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3269941 | HPB | 2010 | 7 Pages |
Abstract
Early and aggressive surgical management of hepatic metastases from neuroendocrine tumours is associated with significant long-term survival rates. Radiofrequency ablation is a reasonable option if a lesion is unresectable. R1 resections, unlike many other cancers, are not associated with a worse overall survival.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Evan S. Glazer, Jennifer F. Tseng, Waddah Al-Refaie, Carmen C. Solorzano, Ping Liu, Katherine A. Willborn, Eddie K. Abdalla, Jean-Nicolas Vauthey, Steven A. Curley,